Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports the long-term safety and tolerability results from a Phase 3 study of Faricimab in participants with Diabetic Macular Edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• VABYSMO (faricimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2024-10-30